Mulberry Leaf Extract for Weight Loss

Verdict: Unproven for weight loss; only indirect evidence

Mulberry leaf extract is not a proven weight-loss aid. No human trial has shown it reduces body weight or body fat, and its only plausible tie to weight is an indirect, unverified one through blunting after-meal blood sugar spikes.

C 🟠 C Weak Evidence Published

🔬Why this grade7-layer evidence engine

This earns a Weak (C) grade because the human evidence for weight loss is essentially absent. The available clinical trials were built around blood sugar and lipids, not body composition. A double-blind RCT of Reducose mulberry extract (PMID 28225835, n=37, industry-funded) measured only a single after-meal glucose and insulin response, with body weight used as an entry criterion rather than an outcome. A small 12-week DNJ-rich extract trial (PMID 20838571, n=10) tracked triglycerides and reported no meaningful weight change.

Nothing higher up fills the gap. A meta-analysis of Morus alba (PMID 26972284) pooled glucose and lipid markers only and did not include body weight, BMI, waist circumference, or body fat at all. The single positive weight signal comes from a mouse study (PMID 23561072), where the active compound DNJ cut visceral fat in high-fat-fed animals. That is preclinical, indirect evidence that cannot be extrapolated to people, and the proposed mechanism, slowing carbohydrate absorption via alpha-glucosidase inhibition, remains biologically plausible but clinically unproven for weight.

Health authorities do not back a weight claim. EFSA concluded a cause-and-effect relationship cannot be established and that the extract is not even sufficiently characterised; NIH/NCCIH reports only mixed blood-sugar findings and flags a real low-blood-sugar risk when combined with diabetes medications. Mayo Clinic, Harvard, the NHS, and obesity-specialty societies do not address it. Note too that some 'mulberry weight-loss' studies actually use mulberry fruit extract, not leaf, and should not be conflated. Bottom line: treat it as unproven for weight loss.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.46
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published
Confidence
84%
Highly consistent evidence
Evidence level
E3
Single high-quality meta-analysis

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.40
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L5 Clinical bodiesAuthoritative stance
0.50
L11 AI re-checkIndependent read
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.457
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Mulberry-extract improves glucose tolerance and decreases insulin concentrations in normoglycaemic adults
PMID: 28225835 2017 RCT (double-blind) n = 37
Finding: Single-dose mulberry leaf extract reduced postprandial glucose AUC (~22% at higher dose) and insulin AUC (~24.7%) vs placebo. Body weight/BMI was an inclusion criterion (BMI 20-30) but NOT a measured outcome; no anthropometric endpoint reported.
⚠️ Industry-funded
View on PubMed
Effects of Mulberry Leaf Extract Rich in 1-Deoxynojirimycin on Blood Lipid Profiles in Humans
PMID: 20838571 2010 隨機對照試驗 n = 10
Finding: Modest decrease in serum triglyceride and beneficial lipoprotein changes after 12 weeks. Body weight and BMI were tracked descriptively but not designated primary outcomes; no significant weight reduction reported in this hypertriglyceridemic cohort.
🟠 Limited quality
View on PubMed
A meta-analysis of efficacy of Morus alba Linn. to improve blood glucose and lipid profile
PMID: 26972284 2017 統合分析
Finding: Morus alba significantly improved postprandial glycaemia and lipid markers. The pooled analysis did NOT include body weight, BMI, waist circumference, or body fat as outcomes; weight loss endpoints were not extractable from included trials.
Academic
View on PubMed
Intake of mulberry 1-deoxynojirimycin prevents diet-induced obesity through increases in adiponectin in mice
PMID: 23561072 2013 Animal Study
Finding: DNJ decreased visceral fat weight and adipocyte size and increased serum adiponectin in HFD mice. Animal-only evidence; no human extrapolation possible.
🟠 Limited quality Academic
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
L4b EU EFSA
Not addressed
A cause and effect relationship cannot be established between the consumption of Morus alba (white mulberry) leaf extract and the claimed effect. The mulberry extract is not sufficiently characterised in relation to the claimed effect. The proposed target population of diabetic patients does not comply with the criteria for disease risk reduction claims. source↗
L4d TW TFDA / 衛福部
Supportive
本產品經動物實驗結果證實:有助於延緩飯後血糖上升,僅供參考。本產品經動物實驗結果證實:有助於降低體脂肪形成(不易形成體脂肪),僅供參考。 source↗
L5a NIH Office of Dietary Supplements
Cautious
Several studies suggest that white mulberry may reduce elevated blood glucose levels, but some of these studies have been preliminary or were not conducted in humans. Other trials have found no effect on blood glucose levels. There is a potential risk for low blood sugar when taken with diabetes medications. source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-weight-loss-INT-mulberry-leaf-extract-001 繁體中文版 →